This trial will test whether a plant-based diet is feasible and effective for people with early stage multiple myeloma.
- Smoldering Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
2 Primary · 0 Secondary · Reporting Duration: 12 weeks
1 Treatment Group
1 of 1
23 Total Participants · 1 Treatment Group
Primary Treatment: Plant based meals · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · All Participants · 8 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the maximum number of people that can join this clinical trial?
"That is accurate. The clinical trial in question, which was first advertised on 6/3/2021, is still looking for 20 individuals to participate. These potential participants can go to one of seven different locations, as listed on clinicaltrials.gov" - Anonymous Online Contributor
Are there any participating hospitals in North America?
"There are a total of 7 enrolling patients for this study. 3 locations are in New York, Uniondale, and Middletown. The other 4 sites are located elsewhere." - Anonymous Online Contributor
Is it still possible to sign up for this research project?
"The clinical trial is still enrolling patients, as indicated by the website clinicaltrials.gov. This information was initially posted on 6/3/2021 and updated as recently as 4/11/2022." - Anonymous Online Contributor